You are here: Home » Companies » News
These tech firms are taking the e-commerce battle to India's hinterlands
Reliance Industries, TA'ZIZ in $2-bn JV for chemical production partnership
Business Standard

Serum may cut Covishield's monthly production by half as govt orders dry up

The Pune-based firm has 500 million doses of Covishield in stock

Topics
Serum Institute of India | Coronavirus Vaccine | Indian companies

BS Reporter  |  New Delhi 



Adar Poonawalla, CEO, Serum Institute
Adar Poonawalla, CEO, Serum Institute

The world’s biggest vaccine maker (SII) on Tuesday said it will reduce the production of the Oxford-Astra­Ze­neca vaccine — marketed as Covishield in India — by at least 50 per cent from next week as government orders have dried up.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, December 08 2021. 00:59 IST

RECOMMENDED FOR YOU

.